gastro-jРоссийский журнал гастроэнтерологии, гепатологии, колопроктологииRussian Journal of Gastroenterology, Hepatology, Coloproctology1382-43762658-6673«Gastro» LLCgastro-j-1977Research ArticleЛЕКЦИИ И ОБЗОРЫLECTURES AND REVIEWSНовая система оценки клинических симптомов гастроэзофагеальной рефлюксной болезниNew system of evaluation of clinical signs of gastroesophageal reflux diseaseШептулинА. А.SheptulinA. A.2008250820081842327Copyright © Шептулин А.А., 20082008Шептулин А.А.Sheptulin A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.gastro-j.ru/jour/article/view/1977

Цель обзора. Провести анализ новой системы оценки клинических симптомов гастроэзофагеальной рефлюксной болезни (ГЭРБ).Полученные данные. В обзоре дана характеристика новой системы оценки клинических симптомов ГЭРБ, получившей название шкалы ReQuest™, которая включает в себя 6 групп клинических симптомов. Проанализированы результаты тестирования этой шкалы в клинических исследованиях, а также возможности ее применения в комбинации с характеристикой эндоскопических изменений по Лос­-Анджелесской классификации.Заключение. Проведенный анализ свидетельствует о том, что новая система оценки клинических симптомов ГЭРБ ReQuest™ дает возможность более детально охарактеризовать клинические проявления болезни и более точно оценить эффективность проводимого лечения.

The aim of review

The aim of review. To carry out analysis of new system of evaluation of clinical signs of gastroesophageal reflux disease (GERD).

Original data

Original data. Review presents the characteristic of new system of evaluation of clinical signs of GERD, named ReQuest™ scale which includes 6 groups of clinical signs. Results of testing by this scale in clinical studies, and potentials of its application in combination to Los Angeles endoscopical classification were analysed.

Conclusion

Conclusion. Analysis, that was carried out, testifies that the new system of evaluation of clinical signs of GERD ReQuest ™ enables more detailed characteristic of clinical manifestations and more precise estimation of treatment efficacy.

ГЭРБклинические симптомысистема оценки ReQuest™GERDclinical signsReQuest ™ evaluation systemReferencesArmstrong D. Symptom assessment: methods and content // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 184–192; (suppl. 3). – P. 211.Armstrong D. Symptom assessment: methods and content // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 184–192; (suppl. 3). – P. 211.Armstrong D., Mцnnikes H., Bardhan K.D., Stanghellini V. The construction of a new evaluative GERD questionnaire – methods and state of the art // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 17–24.Armstrong D., Mцnnikes H., Bardhan K.D., Stanghellini V. The construction of a new evaluative GERD questionnaire – methods and state of the art // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 17–24.Bardhan K.D., Berghцfer P. Look – but also listen! ReQuest™: an assay on a new validated scale to asses the outcome of GERD treatment // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 87–100.Bardhan K.D., Berghцfer P. Look – but also listen! ReQuest™: an assay on a new validated scale to asses the outcome of GERD treatment // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 87–100.Bardhan K.D., Stanghellini V., Armstrong D. et al. Evaluation of GERD symptoms during therapy // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 32–40.Bardhan K.D., Stanghellini V., Armstrong D. et al. Evaluation of GERD symptoms during therapy // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 32–40.Bardhan K.D., Stanghellini V., Armstrong D. et al. International validation of ReQuest™ in patients with endoscopy-negative gastroesophageal reflux disease // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 48–54.Bardhan K.D., Stanghellini V., Armstrong D. et al. International validation of ReQuest™ in patients with endoscopy-negative gastroesophageal reflux disease // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 48–54.Beckering A., Braun W., Sommer M. Process of measuring in clinical medicine – implications of different definitions in clinical therapeutic studies // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 25–31.Beckering A., Braun W., Sommer M. Process of measuring in clinical medicine – implications of different definitions in clinical therapeutic studies // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 25–31.Fass R. Gastroesophageal reflux and sleep // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 154–159.Fass R. Gastroesophageal reflux and sleep // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 154–159.Heading R.C. Complete remission in GERD: dream or reality // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 198–101.Heading R.C. Complete remission in GERD: dream or reality // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 198–101.Hunt R.H., Tytgat G., Malfertheiner P. et al. Whistler consensus // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 47–50.Hunt R.H., Tytgat G., Malfertheiner P. et al. Whistler consensus // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 47–50.Modlin I.M., Malfertheiner P., Hunt R.H. et al. GERD evaluation: time for a new paradigm? // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl.2). – P. 237–241.Modlin I.M., Malfertheiner P., Hunt R.H. et al. GERD evaluation: time for a new paradigm? // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl.2). – P. 237–241.Mцnnikes H. Global clinical symptom spectrum in gastroesophageal reflux disease // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 168–174.Mцnnikes H. Global clinical symptom spectrum in gastroesophageal reflux disease // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 168–174.Mцnnikes H., Bardhan K.D., Stanghellini V. et al. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest™ in erosive GERD // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 41–47.Mцnnikes H., Bardhan K.D., Stanghellini V. et al. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest™ in erosive GERD // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 41–47.Mцnnikes H., Pfaffenberger B., Gatz G. et al. Novel measurement of rapid treatment success with ReQuest™: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 62–68.Mцnnikes H., Pfaffenberger B., Gatz G. et al. Novel measurement of rapid treatment success with ReQuest™: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 62–68.Stanghellini V., Armstrong D., Mцnnikes H, Bard-han K.D. Systematic review: do we need a new gastroesophageal reflux disease questionnaire // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 3–16.Stanghellini V., Armstrong D., Mцnnikes H, Bard-han K.D. Systematic review: do we need a new gastroesophageal reflux disease questionnaire // Digestion. – 2007. – Vol. 75 (suppl. 1). – P. 3–16.Stanghellini V., Barbara G., Cogliandro R. Overlap between GERD and IBS: irrefutable but subtle // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 114–117.Stanghellini V., Barbara G., Cogliandro R. Overlap between GERD and IBS: irrefutable but subtle // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 114–117.Thomson A.B.R. ReQuest: pain, pH, pills and promises // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 81–86.Thomson A.B.R. ReQuest: pain, pH, pills and promises // J. Clin. Gastroenterol. – 2007. – Vol. 41 (suppl. 2). – P. 81–86.

The authors declare that there are no conflicts of interest present.